Hoffmann Vera, Neubauer Henrik, Heinzler Julia, Smarczyk Anna, Hellmich Martin, Bowe Andrea, Kuetting Fabian, Demir Muenevver, Pelc Agnes, Schulte Sigrid, Toex Ullrich, Nierhoff Dirk, Steffen Hans-Michael
From the Clinic for Gastroenterology and Hepatology, University Hospital of Cologne, Kerpener Str. 62, Köln, Germany (HV, NH, HJ, SA, BA, KF, DM, PA, SS, TU, ND, SHM); Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Kerpener Str. 62, Köln, Germany (HM).
Medicine (Baltimore). 2015 Sep;94(38):e1614. doi: 10.1097/MD.0000000000001614.
Acute upper gastrointestinal bleeding (UGIB) is the leading indication for emergency endoscopy. Scoring schemes have been developed for immediate risk stratification. However, most of these scores include endoscopic findings and are based on data from patients with nonvariceal bleeding. The aim of our study was to design a pre-endoscopic score for acute UGIB--including variceal bleeding--in order to identify high-risk patients requiring urgent clinical management. The scoring system was developed using a data set consisting of 586 patients with acute UGIB. These patients were identified from the emergency department as well as all inpatient services at the University Hospital of Cologne within a 2-year period (01/2007-12/2008). Further data from a cohort of 322 patients who presented to our endoscopy unit with acute UGIB in 2009 served for external/temporal validation.Clinical, laboratory, and endoscopic parameters, as well as further data on medical history and medication were retrospectively collected from the electronic clinical documentation system. A multivariable logistic regression was fitted to the development set to obtain a risk score using recurrent bleeding, need for intervention (angiography, surgery), or death within 30 days as a composite endpoint. Finally, the obtained risk score was evaluated on the validation set. Only C-reactive protein, white blood cells, alanine-aminotransferase, thrombocytes, creatinine, and hemoglobin were identified as significant predictors for the composite endpoint. Based on the regression coefficients of these variables, an easy-to-use point scoring scheme (C-WATCH) was derived to estimate the risk of complications from 3% to 86% with an area under the curve (AUC) of 0.723 in the development set and 0.704 in the validation set. In the validation set, no patient in the identified low-risk group (0-1 points), but 38.7% of patients in the high-risk group (≥ 2 points) reached the composite endpoint. Our easy-to-use scoring scheme is able to distinguish high-risk patients requiring urgent endoscopy, from low-risk cases who are suitable candidates for outpatient management or in whom endoscopy may be postponed. Based on our findings, a prospective validation of the C-WATCH score in different patient populations outside the university hospital setting seems warranted.
急性上消化道出血(UGIB)是急诊内镜检查的主要指征。已制定了评分方案用于即刻风险分层。然而,这些评分大多包含内镜检查结果,且基于非静脉曲张出血患者的数据。我们研究的目的是设计一种针对急性UGIB(包括静脉曲张出血)的内镜前评分,以识别需要紧急临床处理的高危患者。该评分系统是利用一个包含586例急性UGIB患者的数据集开发的。这些患者是在两年期间(2007年1月至2008年12月)从科隆大学医院急诊科以及所有住院科室中识别出来的。2009年向我们内镜科室就诊的322例急性UGIB患者队列的进一步数据用于外部/时间验证。临床、实验室和内镜参数,以及关于病史和用药的进一步数据是从电子临床文档系统中回顾性收集的。将多变量逻辑回归应用于开发集,以复发出血、干预需求(血管造影、手术)或30天内死亡作为复合终点来获得风险评分。最后,在验证集上评估获得的风险评分。仅C反应蛋白、白细胞、丙氨酸转氨酶、血小板、肌酐和血红蛋白被确定为复合终点的显著预测因素。基于这些变量的回归系数,得出了一种易于使用的评分方案(C-WATCH),以估计并发症风险从3%到86%,开发集的曲线下面积(AUC)为0.723,验证集为0.704。在验证集中,已识别的低风险组(0 - 1分)中无患者达到复合终点,但高风险组(≥2分)中有38.7%的患者达到了复合终点。我们这种易于使用的评分方案能够区分需要紧急内镜检查的高危患者与适合门诊管理或内镜检查可推迟的低风险病例。基于我们的研究结果,似乎有必要在大学医院环境之外的不同患者群体中对C-WATCH评分进行前瞻性验证。